These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31988792)
1. Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors. Fukuyama Y; Numata K; Yoshino K; Santanda T; Funakoshi H Acute Med Surg; 2020; 7(1):e480. PubMed ID: 31988792 [TBL] [Abstract][Full Text] [Related]
2. Sodium-Glucose Cotransporter-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis Followed by Excessively Low Carbohydrate Diet. Tsutsui E; Hoshina Y; Homma H Cureus; 2021 Jul; 13(7):e16085. PubMed ID: 34345561 [TBL] [Abstract][Full Text] [Related]
3. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature. Diaz-Ramos A; Eilbert W; Marquez D Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052 [TBL] [Abstract][Full Text] [Related]
4. Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet. Hayami T; Kato Y; Kamiya H; Kondo M; Naito E; Sugiura Y; Kojima C; Sato S; Yamada Y; Kasagi R; Ando T; Noda S; Nakai H; Takada E; Asano E; Motegi M; Watarai A; Kato K; Nakamura J J Diabetes Investig; 2015 Sep; 6(5):587-90. PubMed ID: 26417418 [TBL] [Abstract][Full Text] [Related]
5. Euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus 3 days after initiating sodium-glucose cotransporter 2 inhibitor while on an extremely low carbohydrate diet: A case report. Inoue A; Katayama A; Sue M; Hasegawa M; Maeda M; Matoba M; Ishii T; Kuribayashi R; Tenta M; Matsushita Y; Takeda M; Iseda I; Wakatsuki T; Hida K Clin Case Rep; 2022 Nov; 10(11):e6572. PubMed ID: 36408091 [TBL] [Abstract][Full Text] [Related]
6. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. Andrews TJ; Cox RD; Parker C; Kolb J J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592 [TBL] [Abstract][Full Text] [Related]
7. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report]. Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745 [TBL] [Abstract][Full Text] [Related]
8. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report. Alkatheeri A; Alseddeeqi E J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357 [TBL] [Abstract][Full Text] [Related]
9. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report. Yii ESS; Azli AW; Sitaram PN J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625 [TBL] [Abstract][Full Text] [Related]
10. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report. Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104 [TBL] [Abstract][Full Text] [Related]
11. Euglycemic Diabetic Ketoacidosis in Concurrent Very Low-carbohydrate Diet and Sodium-glucose Transporter-2 Inhibitor Use: A Case Report. Earle M; Ault B; Bonney C Clin Pract Cases Emerg Med; 2020 May; 4(2):185-188. PubMed ID: 32426668 [TBL] [Abstract][Full Text] [Related]
12. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report. Vadasz B; Arazi M; Shukha Y; Koren O; Taher R J Med Case Rep; 2021 Feb; 15(1):62. PubMed ID: 33581735 [TBL] [Abstract][Full Text] [Related]
13. Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers. Somagutta MR; Agadi K; Hange N; Jain MS; Batti E; Emuze BO; Amos-Arowoshegbe EO; Popescu S; Hanan S; Kumar VR; Pormento K Cureus; 2021 Mar; 13(3):e13665. PubMed ID: 33824816 [TBL] [Abstract][Full Text] [Related]
14. When Guidelines Fail: Euglycemic Diabetic Ketoacidosis After Bariatric Surgery in a Patient Taking a Sodium-Glucose Cotransporter-2 Inhibitor: A Case Report. Lane S; Paskar D; Hamed S; Goffi A A A Pract; 2018 Jul; 11(2):46-48. PubMed ID: 29634546 [TBL] [Abstract][Full Text] [Related]
15. Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians? Somagutta MKR; Uday U; Shama N; Bathula NR; Pendyala S; Mahadevaiah A; Mahmutaj G; Ngardig NN Korean J Fam Med; 2022 Nov; 43(6):361-366. PubMed ID: 36444120 [TBL] [Abstract][Full Text] [Related]
16. Metabolic ketoacidosis with normal blood glucose: A rare complication of sodium-glucose cotransporter 2 inhibitors. Ullah S; Khan N; Zeb H; Tahir H SAGE Open Med Case Rep; 2016; 4():2050313X16675259. PubMed ID: 27928503 [TBL] [Abstract][Full Text] [Related]
17. Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor. Alhemeiri M; Alseddeeqi E Case Rep Endocrinol; 2022; 2022():4101975. PubMed ID: 35282610 [TBL] [Abstract][Full Text] [Related]
18. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review. Mahfooz RS; Khan MK; Al Hennawi H; Khedr A Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365 [TBL] [Abstract][Full Text] [Related]
19. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report. VonTungeln CD; Al Bataineh M Cureus; 2024 Jan; 16(1):e52122. PubMed ID: 38344581 [TBL] [Abstract][Full Text] [Related]
20. Euglycemic diabetic ketoacidosis in a patient with new-onset type 1 diabetes following a ketogenic diet: a potential risk of a dangerous dietary trend. Helvaci BC; Erdogan BT; Ozdemir D; Topaloglu O; Cakir B Arch Endocrinol Metab; 2024; 68():e230229. PubMed ID: 39420895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]